These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11705479)

  • 21. Integrating injectable opioid agonist treatment into a drug treatment court program: A case study.
    Jun JH; Fairbairn N
    Subst Abus; 2018; 39(4):493-496. PubMed ID: 29949453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Methadone, maintenance program and reduction of drug abuse. An expanding practice].
    Tremblay M
    Perspect Infirm; 2005; 2(3):40-1. PubMed ID: 15686211
    [No Abstract]   [Full Text] [Related]  

  • 23. Evaluation of a minimal services treatment track for noncompliant patients in opioid substitution treatment.
    Calsyn DA; DeMarco FJ; Saxon AJ; Sloan KL; Gibbon KE
    Am J Public Health; 2003 Jul; 93(7):1086-8. PubMed ID: 12835190
    [No Abstract]   [Full Text] [Related]  

  • 24. Quality of life under maintenance treatment with heroin versus methadone in patients with opioid dependence.
    Karow A; Reimer J; Schäfer I; Krausz M; Haasen C; Verthein U
    Drug Alcohol Depend; 2010 Dec; 112(3):209-15. PubMed ID: 20728288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diversified prescription of narcotics to heroin addicts. Basis, design, research plan].
    Uchtenhagen A
    Schweiz Rundsch Med Prax; 1994 Aug; 83(34):931-6. PubMed ID: 7939045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heroin-assisted treatment in Switzerland: a case study in policy change.
    Uchtenhagen A
    Addiction; 2010 Jan; 105(1):29-37. PubMed ID: 19922519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and pharmacodynamics of high doses of pharmaceutically prepared heroin, by intravenous or by inhalation route in opioid-dependent patients.
    Rook EJ; van Ree JM; van den Brink W; Hillebrand MJ; Huitema AD; Hendriks VM; Beijnen JH
    Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):86-96. PubMed ID: 16433897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Economic evaluation of the Swiss project on medically prescribed heroin substitution treatment].
    Frei A
    Psychiatr Prax; 2001 Jul; 28 Suppl 1():S41-4. PubMed ID: 11533906
    [No Abstract]   [Full Text] [Related]  

  • 29. Development of a monitoring system for heroin-assisted substitution treatment in Switzerland.
    Gschwend P; Rehm J; Lezzi S; Blättler R; Steffen T; Gutzwiller F; Uchtenhagen A
    Soz Praventivmed; 2002; 47(1):33-8. PubMed ID: 12050928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality of life profiles and changes in the course of maintenance treatment among 1,015 patients with severe opioid dependence.
    Karow A; Verthein U; Pukrop R; Reimer J; Haasen C; Krausz M; Schäfer I
    Subst Use Misuse; 2011; 46(6):705-15. PubMed ID: 21047149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benzodiazepine use among patients in heroin-assisted vs. methadone maintenance treatment: findings of the German randomized controlled trial.
    Eiroa-Orosa FJ; Haasen C; Verthein U; Dilg C; Schäfer I; Reimer J
    Drug Alcohol Depend; 2010 Dec; 112(3):226-33. PubMed ID: 20708349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longitudinal patterns of cocaine use among patients receiving injectable hydromorphone or diacetylmorphine for the treatment of opioid use disorder: A growth curve modeling approach.
    Palis H; Guh D; MacDonald S; Harrison S; Brissette S; Marsh DC; Schechter MT; Oviedo-Joekes E
    Drug Alcohol Depend; 2021 Jan; 218():108333. PubMed ID: 33268225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful treatment of chronic hepatitis C virus infection in severely opioid-dependent patients under heroin maintenance.
    Schulte B; Schütt S; Brack J; Isernhagen K; Deibler P; Dilg C; Verthein U; Haasen C; Reimer J
    Drug Alcohol Depend; 2010 Jun; 109(1-3):248-51. PubMed ID: 20167441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapeutic prescription of heroin to drug addicts].
    Cancrini L
    Recenti Prog Med; 2001 Jan; 92(1):1-5. PubMed ID: 11260964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Heroin-assisted treatment of opiate addicts--former and current research emphasis].
    Steffen T; Kaufmann B; Blättler R; Dobler-Mikola A; Gutzwiller F; Uchtenhagen A
    Gesundheitswesen; 1999; 61(8-9):407-12. PubMed ID: 10535222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double-blind injectable hydromorphone versus diacetylmorphine for the treatment of opioid dependence: a pilot study.
    Oviedo-Joekes E; Guh D; Brissette S; Marsh DC; Nosyk B; Krausz M; Anis A; Schechter MT
    J Subst Abuse Treat; 2010 Jun; 38(4):408-11. PubMed ID: 20359843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heroin maintenance and attraction to treatment.
    Room R
    Eur J Public Health; 2002 Sep; 12(3):234-5. PubMed ID: 12232965
    [No Abstract]   [Full Text] [Related]  

  • 38. Long-term effects of heroin-assisted treatment in Germany.
    Verthein U; Bonorden-Kleij K; Degkwitz P; Dilg C; Köhler WK; Passie T; Soyka M; Tanger S; Vogel M; Haasen C
    Addiction; 2008 Jun; 103(6):960-6; discussion 967-8. PubMed ID: 18422829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Co-morbidity: psychiatric disorder of opiate addicts at entry into heroin-assisted treatment].
    Frei A; Rehm J;
    Psychiatr Prax; 2002 Jul; 29(5):251-7. PubMed ID: 12101491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outpatient versus inpatient opioid detoxification: a randomized controlled trial.
    Day E; Strang J
    J Subst Abuse Treat; 2011 Jan; 40(1):56-66. PubMed ID: 21036514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.